MOORESVILLE, N.C., Nov. 2, 2021 /PRNewswire/ -- Rick Ware Racing
(RWR) has joined forces once again with Nine Line Apparel and
Biohaven Pharmaceuticals' Nurtec® ODT (rimegepant) to pay tribute
and honor the upcoming 80th Anniversary of the Attack on
Pearl Harbor this weekend at
Phoenix Raceway for the season finale.
The special paint scheme of the Nurtec ODT 51 car depicts a
special tribute to the 80th Anniversary of Pearl Harbor on December 7, 2021. One hundred percent of the
proceeds from the Nine Line Apparel Remembering 80 Years of Infamy
T-shirt will be donated directly to Best Defense Foundation, to
help send sixty World War II veterans to Hawaii next month for a week-long ceremony
honoring those who lost their lives, and those who defended the
front lines when our country needed it the most.
"Throughout the year we have been honored to give back to the
men and women in uniform, as well as honor those who have served
our country and paid the ultimate sacrifice," commented team owner
Rick Ware. "Having great partners
like Nurtec ODT and Nine Line Apparel who continue to drive the
importance of our military and those who have served is humbling.
Paying tribute to the 80th Anniversary Attack on Pearl Harbor and honoring those who tragically
lost their lives that day is an important and special way to close
out the 2021 NASCAR season and our Military Salutes program."
"We have seen firsthand the impact migraine has on our active
duty service members, veterans and their families. Through this
sponsorship of the Rick Ware Racing team, we have been able to
raise awareness of this debilitating disease and how relief may be
available with Nurtec ODT. It is important to us as a company to
support people with migraine and those who have dedicated their
lives for the greater good. We salute the World War II veterans and
the sacrifices they and their families have made," said
Graham Goodrich, Senior Vice
President of Marketing, Biohaven Pharmaceuticals.
"We couldn't be more honored to partner again with Rick Ware
Racing and Nurtec ODT to support our nation's veterans," said
Rich Caponi, Chief Revenue Officer
at Nine Line Apparel. "Being able to support the Best Defense
Foundation's initiative to get these WWII heroes back to
Pearl Harbor to remember, honor,
and bring closure is something that we are humbled and proud to be
a part of."
The Best Defense Foundation was founded in 2018 by former NFL
Linebacker, Donnie Edwards. The
Foundation honors and celebrates our veterans from past conflicts,
including, WWII, Korea, Vietnam
and those who have recently retired. As a monumental anniversary
approaches in December, The Best Defense Foundation is scheduled to
bring sixty World War II veterans back to Pearl Harbor for a "Day That Shall Remain in
Infamy." The veterans will depart from Dallas, Texas on December 3rd, and participate in a four-day event
that will conclude in a special ceremony on December 7th. Through the Foundation, all
expenses will be paid, including airfare and travel accommodations
for both the veterans and their caregivers.
"We are honored to bring veterans back to their battlefields to
rekindle the brotherhood and provide closure on such an
important time for themselves and the world. Our programs are 100%
for the veterans and we pride ourselves on quality programs to
fulfill our mission of taking care of the ones who took
care of us," commented Donnie
Edwards, Executive Director of Best Defense Foundation.
In addition to Rick Ware Racing's participation in next month's
events in Hawaii, the No. 51 car
will be present in The Pearl Harbor Memorial Parade, that is
produced by Historic Programs and has been designated as one
of "America's Living Memorials." This annual Parade commemorates
the Anniversary of the Attack on Pearl
Harbor by Saluting our Veterans, their families and active
military members, while remembering and honoring those who lost
their lives 80 years ago. Historic Programs produces truly
meaningful events by uniting generations of Americans - bringing
our young students to the places where history was made to pay
tribute and learn directly from our history makers. These programs
will educate, honor and inspire Americans for generations to
The season finale at Phoenix Raceway is set for November 7th and will be televised live on NBC.
For more information on Rick Ware Racing, visit www.wareracing.com,
or follow along on social media; Twitter, Facebook,
About Rick Ware Racing
With a rich and extensive
history, Rick Ware Racing has been part of the racing fabric in the
USA for over 30 years. The team
currently fields a team in NASCAR Cup Series, NASCAR Xfinity
Series, NTT INDY CAR Series and NASCAR Pinty's Series. The team
most recently claimed the 2020 Asian Le Mans Series Am
About Nine Line Apparel
Founded in 2012 by Army
Captain and former Special Operations Air Mission Commander
Tyler Merritt, Nine Line Apparel is
a patriotic lifestyle brand based out of Savannah, Georgia. Nine Line is known for
their patriotic designs, and as a give-back organization that
supports our nation's veterans and first responders through the
Nine Line Foundation and other non-profit initiatives. To learn
more, visit ninelineapparel.com.
About Best Defense Foundation
What began as a simple
conversation during a chance meeting with a WWII veteran has turned
into Donnie's life mission. Inspired by stories from his
grandfather, a Pearl Harbor
survivor, Donnie has worked tirelessly to take WWII veterans back
to the battlefields where they served.
To date, the Foundation has taken over 100 WWII veterans on
battlefield return programs to remember their fallen comrades and
gain closure of a time in their life that had an impact on the
world. Through our Battlefield Return programs, WWII veterans
travel all over the world including to Normandy, the Netherlands, Germany, Belgium, Pearl
Harbor, Iwo Jima, Guam,
Saipan, and Tinian for commemorations.
In addition to the Battlefield Return Program, the Foundation
created a Transition Program to help retired Special Forces
operators return to civilian life and connect with the community
around them. Utilizing Donnie's NFL network, we bring the
professional athlete world together with special forces to help
each other grow.
Finally, the last mission of the Best Defense Foundation is to
educate future generations about the heroism and sacrifices of
those who have served through the preservation of their stories. To
date, we have interviewed over 200 WWII veterans with a video
archive of more than 2000 hours of first hand accounts of the
history that is taught today. Our Education Initiative
curates a curriculum from this media content and uses it to
preserve the legacy of those who sacrificed for us.
About NURTEC ODT
NURTEC ODT (rimegepant) is the first
and only calcitonin gene-related peptide (CGRP) receptor antagonist
available in a quick-dissolve ODT formulation that is approved by
the U.S. Food and Drug Administration (FDA) for the acute
treatment of migraine with or without aura and the preventive
treatment of episodic migraine in adults. The activity of the
neuropeptide CGRP is thought to play a causal role in migraine
pathophysiology. NURTEC ODT is a CGRP receptor antagonist that
works by reversibly blocking CGRP receptors, thereby inhibiting the
biologic activity of the CGRP neuropeptide. The recommended dose of
NURTEC ODT is 75 mg, taken as needed, up to once daily to treat or
every other day to help prevent migraine attacks. For more
information about NURTEC ODT, visit www.nurtec.com. The most
common adverse reaction was nausea and abdominal pain/indigestion.
Avoid concomitant administration of NURTEC ODT with strong
inhibitors of CYP3A4, strong or moderate inducers of CYP3A or
inhibitors of P-gp or BCRP. Avoid another dose of NURTEC ODT within
48 hours when it is administered with moderate inhibitors of
NURTEC ODT orally disintegrating tablets is
a prescription medicine that is used to treat migraine in adults.
It is for the acute treatment of migraine attacks with or without
aura and the preventive treatment of episodic migraine. It is not
known if NURTEC ODT is safe and effective in children.
Important Safety Information|
Do not take NURTEC
ODT if you are allergic to NURTEC ODT (rimegepant) or any
of its ingredients.
Before you take NURTEC ODT, tell your healthcare
provider (HCP) about all your medical conditions, including if
- have liver problems,
- have kidney problems,
- are pregnant or plan to become pregnant,
- breastfeeding or plan to breastfeed.
Tell your HCP about all the medicines you
take, including prescription and over-the-counter
medicines, vitamins, and herbal supplements.
NURTEC ODT may cause serious side effects including allergic
reactions, including trouble breathing and rash. This can happen
days after you take NURTEC ODT. Call your HCP or get emergency help
right away if you have swelling of the face, mouth, tongue, or
throat or trouble breathing. This occurred in less than 1% of
patients treated with NURTEC ODT.
The most common side effects of NURTEC ODT were
nausea (2.7%) and stomach pain/indigestion (2.4%). These are not
the only possible side effects of NURTEC ODT. Tell your HCP if you
have any side effects.
You are encouraged to report side effects of
prescription drugs to the FDA.
Visit www.fda.gov/medwatch or
call 1–800–FDA–1088 or report side effects
to Biohaven at 1–833–4NURTEC.
Please click here for full Prescribing
Information and Patient Information.
Biohaven (NYSE: BHVN) is a
commercial-stage biopharmaceutical company with a portfolio of
innovative, best-in-class therapies to improve the lives of
patients with debilitating neurological and neuropsychiatric
diseases, including rare disorders. Biohaven's neuroinnovation
portfolio includes FDA-approved NURTEC ODT (rimegepant) for the
acute and preventive treatment of migraine and a broad pipeline of
late-stage product candidates across three distinct mechanistic
platforms: CGRP receptor antagonism for the acute and preventive
treatment of migraine; glutamate modulation for
obsessive-compulsive disorder, Alzheimer's disease, and
spinocerebellar ataxia; and MPO inhibition for amyotrophic lateral
sclerosis. More information about Biohaven is available
This news release includes forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995.
These forward-looking statements involve substantial risks and
uncertainties, including statements that are based on the current
expectations and assumptions of Biohaven's management about NURTEC
ODT as an acute treatment for patients with migraine and preventive
treatment for migraine. Factors that could affect these
forward-looking statements include those related to: Biohaven's
ability to effectively commercialize NURTEC ODT, delays or problems
in the supply or manufacture of NURTEC ODT, complying with
applicable U.S. regulatory requirements, the expected timing,
commencement and outcomes of Biohaven's planned and ongoing
clinical trials, the timing of planned interactions and filings
with the FDA, the timing and outcome of expected regulatory
filings, the potential commercialization of Biohaven's product
candidates, the potential for Biohaven's product candidates to be
first in class or best in class therapies and the effectiveness and
safety of Biohaven's product candidates. Various important
factors could cause actual results or events to differ materially
from those that may be expressed or implied by our forward-looking
statements. Additional important factors to be considered in
connection with forward-looking statements are described in the
"Risk Factors" section of Biohaven's Annual Report on Form 10-K for
the year ended December 31, 2020,
filed with the Securities and Exchange Commission on March 1,
2021, and Biohaven's subsequent filings with the Securities and
Exchange Commission. The forward-looking statements are made as of
this date and Biohaven does not undertake any obligation to update
any forward-looking statements, whether as a result of new
information, future events or otherwise, except as required by
NURTEC and NURTEC ODT are registered trademarks of Biohaven
Pharmaceutical Ireland DAC.
Neuroinnovation is a trademark of Biohaven Pharmaceutical Holding
Vlad Coric, M.D.
Chief Executive Officer
Sam Brown Inc.
Rick Ware Racing Contact:
View original content to download
SOURCE Biohaven Pharmaceutical Holding Company Ltd.